Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SITAGLIPTIN MALATE | 100MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-24 | 252066 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18017 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2019-09-05 | 2020-04-09 | 93149 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-10-10 | 94861 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2019-11-28 | 2020-04-02 | 99944 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-01-17 | 2020-04-02 | 103555 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104330 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2020-07-09 | 2020-09-03 | 119895 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Actual shortage | 2024-08-30 | 2025-03-13 | 236376 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2024-09-05 | 2025-01-23 | 236819 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-11-11 | 2022-04-21 | 149113 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2021-12-17 | 2024-05-30 | 151465 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-01-07 | 2022-08-19 | 152417 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194167 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195456 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2023-06-19 | 2024-05-30 | 195481 |
| TEVA-SOLIFENACIN | 10MG | TABLET | Resolved | 2022-05-19 | 2022-08-09 | 161006 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2022-06-09 | 2022-08-09 | 162300 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195506 |
| TEVA-SOLIFENACIN | 5MG | TABLET | Resolved | 2023-06-19 | 2024-06-07 | 195652 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |